AGIOS PHARMACEUTICALS, INC. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

AGIOS PHARMACEUTICALS, INC. has filed 1,297 SEC EDGAR filings since 01 Jul 2008

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page

25

Current page

12

SC 13G/A File 005-87570

SEC SCHEDULE 13G

Filing date: 09 Nov 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36014

10-Q

Filing date: 02 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36014

8-K

Filing date: 02 Nov 2023
Reporting date: 02 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 28 Sep 2023
Reporting date: 26 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Aug 2023
Reporting date: 17 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Aug 2023
Reporting date: 11 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Aug 2023
Reporting date: 11 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Aug 2023
Reporting date: 09 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Aug 2023
Reporting date: 08 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Aug 2023
Reporting date: 07 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36014

10-Q

Filing date: 03 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36014

8-K

Filing date: 03 Aug 2023
Reporting date: 03 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 02 Aug 2023
Reporting date: 01 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jul 2023
Reporting date: 01 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 30 Jun 2023
Reporting date: 28 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2023
Reporting date: 21 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2023
Reporting date: 21 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2023
Reporting date: 21 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2023
Reporting date: 21 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .